The Valley Desk

NCT04732416 · Interventional trial

HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)

Overall registry status Active not recruiting

Phase 2

Conditions Congenital Hyperinsulinism

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov